Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints.

Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints.

Show other versions (1)

Non-alcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD) and a disease with high unmet medical need. Platform trials provide great benefits for sponsors and trial participants in terms of accelerating drug development programs. In this article, we desc...

Full description

Bibliographic Details
Main Authors: Elias Laurin Meyer, Peter Mesenbrink, Nicholas A Di Prospero, Juan M Pericàs, Ekkehard Glimm, Vlad Ratziu, Elena Sena, Franz König, EU-PEARL NASH Investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0281674

Internet

https://doi.org/10.1371/journal.pone.0281674

Similar Items